Benchling
Benchling provides a cloud-based R&D platform for life sciences, featuring an Electronic Lab Notebook to unify and accelerate research.
Secondary Market Price
Secondary Market Price
How benchling.com Measures Up
To help you manage your benchling.com equity, Prospect has run the company through our machine learning model.
Prospect Rating
TBD
We are still gathering data and evaluating benchling.com. Check back soon for our rating on the company's potential worth four years from now.
Exit Risk
TBD
We are still gathering data on benchling.com to train our machine learning model. Check back soon for our exit risk rating for benchling.com!
Funding Stage
Series F
A company at the Series F stage, like Benchling, is quite mature, suggesting more stability and structure than a brand-new startup. This typically means you'll find well-defined roles and processes, trading some of the high-risk, high-reward equity of an early-stage venture for a more established career path.
Secondary Market Price Chart
The secondary market prices for benchling.com shown here are a limited preview. Create a free account to access real-time secondary market prices
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future benchling.com Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for benchling.com's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Benchling is a software development company that provides a cloud-based platform for research and development in the life sciences industry. Its main offering, the Benchling R&D Cloud, is used by over 200,000 scientists in academic, startup, and large biopharmaceutical settings to design DNA, collaborate on experiments, and manage research workflows. Founded in 2012 by Sajith Wickramasekara, Ashu Singhal, and Cory Li, the company has grown significantly, establishing offices in San Francisco, Boston, Zürich, and Belfast. Benchling has expanded its capabilities through multiple funding rounds, including a Series F in 2021, and strategic acquisitions such as PipeBio and Overwatch Research.
The company's current focus is on integrating automation and artificial intelligence into its platform to support the increasing complexity of biotechnology research. Recent activities reflect this direction, including presentations at industry events like BiotechXEurope on using AI to reduce manual work in labs. Benchling has also announced collaborations, such as an integrated solution with PipeBio for next-generation antibody development. The platform's real-world application is demonstrated through its support for customers like uniQure, which recently reported positive data for its Huntington's Disease gene therapy research.
- Andreessen Horowitz
- Tiger Global
- ICONIQ
- Menlo Ventures
- Thrive Capital
- Lux Capital
- Benchmark
- Spark
- Franklin Templeton
- F-Prime
- Elad Gil
- Altimeter
- Alkeon
- Lead Edge
- Lone Pine Capital
- Edge Capital
- Co-Founder, CEO Sajith Wickramasekara
- Co-Founder, President Ashu Singhal
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is benchling.com worth joining?
Deciding if a startup is worth joining requires a careful look at your job offer, including the potential value of your equity. Platforms like Prospect can help you evaluate the equity component by providing data-driven projections and comparing your offer to others in the market.
What should I do with my benchling.com stock?
Managing your startup stock depends on your personal financial goals and the company's stage. Prospect offers tools to help you create a personalized strategy, including tax-optimized plans for exercising options and guidance on when to sell.
Can you sell benchling.com stock?
As a private company, selling Benchling stock is typically possible through secondary markets or company-approved tender offers. Tools like Prospect can help you navigate these opportunities by providing access to secondary market prices and helping you decide how much to sell.
How can I find the value of my benchling.com stock?
The value of private stock is determined by factors like the company's 409A valuation, recent funding rounds, and secondary market demand. You can use Prospect's platform to get a clearer picture, as it uses predictive models and market data to project your equity's future value.
What is benchling.com's equity worth?
The total worth of Benchling's equity is dynamic and depends on its valuation, which changes with new funding rounds and business performance. To estimate what your specific equity grant could be worth, you can use resources like Prospect's Equity Calculator and predictive valuation models.
What is benchling.com's stock ticker symbol?
Since Benchling is a private company, it is not traded on a public stock exchange and therefore does not have a stock ticker symbol. Ticker symbols are only assigned to companies once they become publicly listed through an Initial Public Offering (IPO).
Can I buy or sell benchling.com stock?
Selling stock in a private company like Benchling is often possible for employees during specific events like tender offers, while buying it is typically restricted to accredited investors and employees. Prospect provides tools to help employees optimize their selling strategy but does not directly facilitate the buying or selling of shares.
What is the criteria to buy or invest in benchling.com stock?
Investing in a private company like Benchling is generally limited to accredited investors who can participate in private funding rounds or purchase shares on secondary markets. Employees may also have the opportunity to acquire stock through their equity compensation packages.
